Trishula Therapeutics

1 follower

Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

1-10

Links

This is an unverified company page

Org chart

Anil Singhal

President & CEO

Collapse

Alan Luk

VP, CMC

Anh Tran

Head of Clinical Operations

Siddhartha Mitra

Chief Medical Officer

Board & advisors

Director

Director

Director

Director

Director

Teams

Offices

Similar companies

Gilead Sciences

148 followers

Regeneron

111 followers

Illumina

76 followers

Agilent Technologies

77 followers

Verily Life Sciences

42 followers

Alexion Pharmaceuticals

41 followers

GRAIL

27 followers

Cytiva

13 followers

PerkinElmer

9 followers

Editas Medicine

5 followers

Organogenesis

4 followers

Explore companies

Trishula Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Data Management

Offices

Similar companies